Trader consensus on Polymarket prices a 75.5% implied probability of the CDC issuing a Level 3 Travel Health Notice (Avoid Nonessential Travel) by December 31, 2026, driven primarily by a recent hantavirus outbreak linked to a polar cruise ship, where the CDC activated its Emergency Operations Center at Level 3 for enhanced monitoring amid confirmed cases among U.S. passengers and early signs of limited person-to-person spread. This follows March 2026 advisories for polio in 32 countries and dengue in 16 others, both at Level 2, amid ongoing H5N1 avian influenza concerns, including mutations in a severe Louisiana case enabling better human receptor binding per CDC genomic analysis. With no current Level 3 notices, traders weigh escalating surveillance data against inherent outbreak uncertainties, awaiting weekly FluView updates and epidemiological reports.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$117,078 Wol.
$117,078 Wol.
Dec 31, 2026
$117,078 Wol.
$117,078 Wol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket prices a 75.5% implied probability of the CDC issuing a Level 3 Travel Health Notice (Avoid Nonessential Travel) by December 31, 2026, driven primarily by a recent hantavirus outbreak linked to a polar cruise ship, where the CDC activated its Emergency Operations Center at Level 3 for enhanced monitoring amid confirmed cases among U.S. passengers and early signs of limited person-to-person spread. This follows March 2026 advisories for polio in 32 countries and dengue in 16 others, both at Level 2, amid ongoing H5N1 avian influenza concerns, including mutations in a severe Louisiana case enabling better human receptor binding per CDC genomic analysis. With no current Level 3 notices, traders weigh escalating surveillance data against inherent outbreak uncertainties, awaiting weekly FluView updates and epidemiological reports.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Rynek otwarty: Jan 19, 2026, 3:15 PM ET
Wolumen
$117,078Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket prices a 75.5% implied probability of the CDC issuing a Level 3 Travel Health Notice (Avoid Nonessential Travel) by December 31, 2026, driven primarily by a recent hantavirus outbreak linked to a polar cruise ship, where the CDC activated its Emergency Operations Center at Level 3 for enhanced monitoring amid confirmed cases among U.S. passengers and early signs of limited person-to-person spread. This follows March 2026 advisories for polio in 32 countries and dengue in 16 others, both at Level 2, amid ongoing H5N1 avian influenza concerns, including mutations in a severe Louisiana case enabling better human receptor binding per CDC genomic analysis. With no current Level 3 notices, traders weigh escalating surveillance data against inherent outbreak uncertainties, awaiting weekly FluView updates and epidemiological reports.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Wolumen
$117,078Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus on Polymarket prices a 75.5% implied probability of the CDC issuing a Level 3 Travel Health Notice (Avoid Nonessential Travel) by December 31, 2026, driven primarily by a recent hantavirus outbreak linked to a polar cruise ship, where the CDC activated its Emergency Operations Center at Level 3 for enhanced monitoring amid confirmed cases among U.S. passengers and early signs of limited person-to-person spread. This follows March 2026 advisories for polio in 32 countries and dengue in 16 others, both at Level 2, amid ongoing H5N1 avian influenza concerns, including mutations in a severe Louisiana case enabling better human receptor binding per CDC genomic analysis. With no current Level 3 notices, traders weigh escalating surveillance data against inherent outbreak uncertainties, awaiting weekly FluView updates and epidemiological reports.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania